Oncotarget

Corrections:

Correction: Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning

PDF  |  How to cite

Oncotarget. 2019; 10:2235-2235. https://doi.org/10.18632/oncotarget.26806

Metrics: PDF 558 views  |   ?  

Zhi Guo1,2, Xiao-dong Liu2 and Hui-ren Chen2

1 Department of Medical Oncology, National Cancer Center/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China
2 Department of Hematology, PLA Army General Hospital, Beijing, 100700, China

Correspondence to: Zhi Guo, email: guozhi77@126.com

Published: March 15, 2019

This article has been corrected: The correct author information, author affiliation and Corresponding author details are given below:

Zhi Guo1,2, Xiao-dong Liu2 and Hui-ren Chen2

1 Department of Medical Oncology, National Cancer Center/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China
2 Department of Hematology, PLA Army General Hospital, Beijing, 100700, China

Correspondence to: Zhi Guo, email: guozhi77@126.com

Original article: Oncotarget. 2018; 9:524-538. DOI: https://doi.org/10.18632/oncotarget.22612.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26806